AI Assistant
Blog
Pricing
Log In
Sign Up
P617. Immunogenicity after switching from reference infliximab to biosimilar in children with Crohn’s disease
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
